Board to consider First Interim Dividend
Amrutanjan Health Care Ltd has informed BSE that a meeting of the Board of Directors is scheduled to be held on November 01, 2018 inter alia, to consider and approve, the:1. Un-audited Financial Results along with the Limited Review Report for the quarter ended September 30, 2018.2. Declaration of First Interim Dividend for the Financial Year 2018-19... Board Meeting Intimation for Intimation Of Board Meeting - Under Regulation 29 Of The SEBI LODR
AMRUTANJAN HEALTH CARE LTD.-$has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/11/2018 ,inter alia, to consider and approve Amrutanjan has informed BSE that Pursuant to regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 , a meeting of the Board of Directors is scheduled to be held on Thursday, November 1, 2018 at the registered office of the Company to consider and approve, inter-alia, the :... Shareholding for the Period Ended September 30, 2018
Amrutanjan Health Care Ltd has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2018. For more details, kindly Click here Compliance Certificate For The Period Ended September 30, 2018
The certificate issued by the SEBI registered Registrar and Transfer Agent; M/s. Cameo Corporate Services Limited; certifying that all activities in relation to both the physical and electronic transfer facility are maintained by them for Amrutanjan Health Care Limited is enclosed. Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- M SrinivasanDesignation :- Company Secretary and Compliance Officer Statement Of Investor Complaints For The Quarter Ended September 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- M SrinivasanDesignation :- Company Secretary and Compliance Officer Compliance -Regulation 40(9) And 40(10) Of Securities Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
Pursuant to Regulation 40(9) and 40(10) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the Certificate issued by the Practising Company Secretary, M/s. P Sriram and Associates for the half year ended September 30, 2018 Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
We wish to inform that the 81st Annual General Meeting (AGM) of the members of the Company was held on Monday, September 17, 2018 at 10.30 A.M. at Narada Gana Sabha (Sathguru Gnanananda Hall), No.314, (Old No.254), T.T.K Road, Chennai 600 018. The following is submitted in this regard : 1. Voting results of remote e-voting and Poll conducted at the AGM... Shareholder Meeting / Postal Ballot-Outcome of AGM
We wish to inform that the 81st Annual General Meeting (AGM) of the members of the Company was held on Monday, September 17, 2018 at 10.30 A.M. at Narada Gana Sabha (Sathguru Gnanananda Hall), No.314, (Old No.254), T.T.K Road, Chennai 600 018 and the proceedings of the same are attached. The proceedings shall also be uploaded on the website of the Company www.amrutanjan.com Clarification
With reference to increase in volume, Amrutanjan Health Care Ltd has submitted to BSE a copy of Clarification is enclosed.